| Index | — | P/E | 33.30 | EPS (ttm) | 4.12 | Insider Own | 1.25% | Shs Outstand | 63.58M | Perf Week | 8.42% |
| Market Cap | 8.72B | Forward P/E | 22.21 | EPS next Y | 6.18 | Insider Trans | -5.14% | Shs Float | 62.97M | Perf Month | 13.51% |
| Enterprise Value | 9.89B | PEG | 1.96 | EPS next Q | — | Short Float | 3.29% | Perf Quarter | 0.31% | ||
| Income | 268.00M | P/S | 2.19 | EPS this Y | -3.80% | Short Ratio | 4.53 | Perf Half Y | 15.27% | ||
| Sales | 3.99B | P/B | 3.28 | EPS next Y | 12.41% | ROA | 5.23% | Short Interest | 2.07M | Perf YTD | 12.50% |
| Book/sh | 41.85 | P/C | 41.15 | EPS next 5Y | 12.66% | ROE | 10.14% | 52W High | 146.91 -6.61% | Perf Year | 10.37% |
| Cash/sh | 3.33 | P/FCF | 29.57 | EPS past 3/5Y | 17.88% 12.87% | ROIC | 8.45% | 52W Low | 103.23 32.91% | Perf 3Y | 12.12% |
| Dividend Est. | 2.00 (1.46%) | EV/EBITDA | 13.53 | Sales past 3/5Y | 4.37% 5.22% | Gross Margin | 28.09% | Volatility | 2.35% 1.91% | Perf 5Y | 7.38% |
| Dividend TTM | 1.44 (1.05%) | EV/Sales | 2.48 | EPS Y/Y TTM | -34.08% | Oper. Margin | 12.09% | ATR (14) | 3.06 | Perf 10Y | 80.60% |
| Dividend Ex-Date | Nov 12, 2026 | Quick Ratio | 1.03 | Sales Y/Y TTM | 9.01% | Profit Margin | 6.69% | RSI (14) | 77.37 | Recom | 2.72 |
| Dividend Gr. 3/5Y | 6.38% 4.91% | Current Ratio | 1.50 | EPS Q/Q | -6.17% | SMA20 | 10.20% | Beta | 0.33 | Target Price | 148.33 |
| Payout | 46.24% | Debt/Eq | 0.52 | Sales Q/Q | 6.04% | SMA50 | 9.01% | Rel Volume | 2.22 | Prev Close | 130.64 |
| Employees | 14,000 | LT Debt/Eq | 0.39 | Earnings | Feb 04 | SMA200 | 8.08% | Avg Volume | 453.70K | Price | 137.20 |
| IPO Date | Apr 23, 1993 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.34% 3.91% | Net Debt/EBITDA | 1.59 | Volume | 1,007,388 | Change | 5.02% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-09-26 | Initiated | UBS | Neutral | $135 |
| Oct-07-26 | Initiated | Deutsche Bank | Buy | $150 |
| Jul-15-26 | Reiterated | Raymond James | Outperform | $150 → $160 |
| Mar-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight | |
| Feb-09-26 | Reiterated | Robert W. Baird | $145 → $156 | |
| Jan-09-26 | Reiterated | KeyBanc | Hold | $220 |
| Jan-06-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | |
| Nov-03-25 | Reiterated | Robert W. Baird | $160 → $145 | |
| Nov-03-25 | Reiterated | Wells Fargo | Overweight | $125 → $133 |
| Oct-28-24 | Reiterated | Robert W. Baird | $110 → $185 |
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,992 | 3,777 | 3,583 | 3,487 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,871 | 2,660 | 2,227 | 2,224 | — | — | — | — | — | |
| Gross Profit | 1,121 | 1,117 | 1,356 | 1,263 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 487 | 500 | 582 | 566 | — | — | — | — | — | |
| Research and Development | 486 | 105 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -334 | 0 | 277 | 293 | — | — | — | — | — | |
| Operating Income | 483 | 512 | 496 | 404 | — | — | — | — | — | |
| Interest Expense | 66 | 53 | 44 | 40 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -56 | 32 | 17 | 11 | — | — | — | — | — | |
| Net Income Before Taxes | 361 | 491 | 470 | 375 | — | — | — | — | — | |
| Income Taxes | 93 | 99 | 96 | 91 | — | — | — | — | — | |
| Consolidated Net Income | 268 | 393 | 375 | 284 | — | — | — | — | — | |
| Net Income From Continuing Operations | 268 | 392 | 374 | 284 | — | — | — | — | — | |
| Net Income | 268 | 393 | 375 | 284 | — | — | — | — | — | |
| EPS (Recurring) | 4.16 | 5.97 | 5.65 | 4.34 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.16 | 5.97 | 5.65 | 4.34 | — | — | — | — | — | |
| EPS (Diluted) | 4.12 | 5.88 | 5.53 | 4.25 | — | — | — | — | — | |
| EBITDA | 731 | 831 | 777 | 664 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 33.30 | 20.74 | 28.41 | 29.09 | — | — | — | — | — | |
| Price To Sales Ratio | 2.20 | 2.13 | 2.89 | 2.34 | — | — | — | — | — | |
| Gross Margin | 28.08 | 29.57 | 37.85 | 36.22 | — | — | — | — | — | |
| Operating Margin | 12.10 | 13.56 | 13.84 | 11.59 | — | — | — | — | — | |
| Net Margin | 6.71 | 10.41 | 10.47 | 8.14 | — | — | — | — | — | |
| Shares Outstanding | 64 | 66 | 66 | 66 | — | — | — | — | — | |
| Market Capitalization | 8,781 | 8,049 | 10,369 | 8,159 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Vinczeller Shiela | Chief Human Resources Officer | Sep 02 '26 | Sale | 130.37 | 765 | 99,733 | 26,313 | Sep 03 |
| Touya Gael | Segment Pres., CEO Designate | Aug 27 '26 | Sale | 133.76 | 3,740 | 500,276 | 29,102 | Aug 28 |
| Prieur Marc | Segment President | Aug 04 '26 | Sale | 136.26 | 3,500 | 476,897 | 15,823 | Aug 05 |
| Tanda Stephan B. | President and CEO | Aug 03 '26 | Option Exercise | 74.79 | 9,838 | 735,784 | 248,567 | Aug 04 |
| Tanda Stephan B. | President and CEO | Aug 03 '26 | Sale | 136.16 | 9,838 | 1,339,588 | 238,729 | Aug 04 |
| Tlili Hedi | Segment President | Aug 03 '26 | Sale | 135.00 | 8,854 | 1,195,290 | 15,379 | Aug 03 |
| Prieur Marc | Segment President | Jun 09 '26 | Sale | 115.58 | 5,000 | 577,894 | 19,323 | Jun 10 |
| Vinczeller Shiela | Chief Human Resources Officer | Jun 04 '26 | Sale | 112.61 | 3,555 | 400,341 | 27,078 | Jun 05 |
| Gong Xiangwei | President, Asia | May 26 '26 | Sale | 116.13 | 4,200 | 487,765 | 10,774 | May 27 |
| Hudson Irene Elizabeth | EVP and Chief Legal Officer | May 07 '26 | Option Exercise | 111.38 | 842 | 93,782 | 2,322 | May 08 |
| Hudson Irene Elizabeth | EVP and Chief Legal Officer | May 07 '26 | Sale | 123.43 | 1,264 | 156,013 | 1,480 | May 08 |
| Touya Gael | Segment President | Feb 18 '26 | Sale | 141.35 | 3,500 | 494,739 | 27,963 | Feb 19 |
| Prieur Marc | Segment President | Feb 10 '26 | Sale | 137.81 | 2,000 | 275,620 | 13,745 | Feb 11 |
| Ackerman Daniel | Chief Accounting Officer | Dec 12 '25 | Option Exercise | 71.12 | 15,000 | 1,066,800 | 44,607 | Dec 15 |
| Ackerman Daniel | Chief Accounting Officer | Dec 12 '25 | Sale | 121.23 | 15,000 | 1,818,435 | 29,607 | Dec 15 |